Company: BACC
Filing Date: 2025-06-02
Form Type: S-1/A
Source: 0001185185-25-000574
Chunk: 239

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-06-02
Form: S-1/A
Chunk 239
---

and Medical Director of the Federal Bureau of Prisons. From 2007, Dr. Moritsugu was the Vice President for Global Professional Education
and Strategic Relations for Johnson & Johnson’s Diabetes Solutions Companies, and former Worldwide Chairman of the Johnson
& Johnson (JJDI), until his retirement from Johnson & Johnson in 2013. He served as the Interim Chief Science and Medical Officer
of the American Diabetes Association from August 2019 through June 2020. Dr. Moritsugu attended Chaminade College of Honolulu and earned
a baccalaureate Degree with Honors from the University of Hawaii and a Master of Public Health in Health Administration and Planning
from the University of California, Berkeley. Dr. Moritsugu is Board certified in Preventive Medicine; holds Fellowships in the American
College of Preventive Medicine, the Royal Society of Public Health, the Royalty Society of Medicine, and the National Academy of Public
Administration; and is a Certified Correctional Health Professional. He is an Adjunct Professor of Global Health at the George Washington
University of Public Health and Adjunct Associate Professor of Preventive Medicine at the Uniformed Services University of the Health
Sciences. Dr. Moritsugu is qualified to serve as a director due to his management experience.

<div align='center'>142</div>

Nadim Qureshi,
director nominee, is the managing partner of BPGC Management LP, a global private equity firm focused on transactions with the global
industrials, materials and chemicals sectors, which he co-founded in 2020, where he is responsible for all aspects of firm and investment
management. Mr. Qureshi has served as a director and officer of special purpose companies -- as Chairman of the Board, Chief Executive
Officer and a director of BPGC Acquisition Corp. (formerly known as Ross Acquisition Corp II) since November 12, 2024 and prior thereto
as Head of M&A since its inception in January 2021, as Vice President and Chief Strategy Officer of Quinpario Acquisition Corp. (“Quinpario”)
from May 13, 2013 until June 30, 2014, and as a Managing Director for WL Ross & Co. LLC, an affiliate of the sponsor of WL Ross Holding
Corp., Mr. Qureshi supervised the Business Combination of WL Ross Holding Corp. with Nexeo Solutions, Inc. and served as a board member
of the combined company from 201